Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma

被引：0
作者：
Xu Feng
Guo-Ying Feng
Jie Tao
Yu-Pei Ao
Xin-Hua Wu
Shi-Guai Qi
Zheng-Rong Shi
机构：
[1] The First Affiliated Hospital of Chongqing Medical University,Department of Hepatobiliary Surgery
[2] Army Medical University,Department of Hepatobiliary Surgery, Daping Hospital
[3] The Second Affiliated Hospital of Chongqing Medical University,Infection and Liver Disease Center
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Hepatocellular carcinoma; Hepatectomy; Adjuvant therapy; Network meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10505 / 10518
页数：13
相关论文
共 50 条
  • [1] Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma
    Feng, Xu
    Feng, Guo-Ying
    Tao, Jie
    Ao, Yu-Pei
    Wu, Xin-Hua
    Qi, Shi-Guai
    Shi, Zheng-Rong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10505 - 10518
  • [2] Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection
    Li, Qingli
    Song, Tianqiang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] RISK　FACTORS　FOR　RECURRENCE　IN　PATIENTS　WITH　HEPATOCELLULAR　CARCINOMA　AFTER　RADICAL　RESECTION
    张博恒
    周信达
    余业勤
    汤钊猷
    Chinese Journal of Cancer Research, 1994, (01) : 58 - 62
  • [4] Adjuvant donafenib for hepatocellular carcinoma patients at high-risk of recurrence after radical resection: a real-world experience
    Zhang, Shenyu
    Yang, Guibin
    Song, Ruipeng
    Wang, Wei
    Meng, Fanzheng
    Yin, Dalong
    Wang, Jiabei
    Zhang, Shugeng
    Cai, Wei
    Liu, Yao
    Luo, Dayong
    Wang, Jizhou
    Liu, Lianxin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [5] Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factors
    Gao, Zhendong
    Du, Gang
    Pang, Yuguang
    Fu, Zhihao
    Liu, Chongzhong
    Liu, Yi
    Zhou, Binghai
    Kong, Du
    Shi, Binyao
    Jiang, Zhengcheng
    Jin, Bin
    MEDICINE, 2017, 96 (33)
  • [6] Efficacy and safety of anlotinib as an adjuvant therapy in hepatocellular carcinoma patients with a high risk of postoperative recurrence
    Wang, Jianguo
    Xiang, Xiaonan
    Shi, Zhixiong
    Zhang, Hui
    Zhang, Quanbao
    Liu, Zhikun
    Zhao, Guangjie
    Wu, Chuanxing
    Wei, Qiang
    Zhong, Lin
    Wang, Zhengxin
    Lv, Guoyue
    Zheng, Shusen
    Xu, Xiao
    CHINESE JOURNAL OF CANCER RESEARCH, 2023, 35 (04) : 399 - 407
  • [7] Risk Factors Influencing Recurrence, Patterns of Recurrence, and the Efficacy of Adjuvant Therapy After Radical Resection for Gallbladder Carcinoma
    Kim, Woo Seok
    Choi, Dong Wook
    You, Dong Do
    Ho, Chuan Yu
    Heo, Jin Seok
    Choi, Seong Ho
    JOURNAL OF GASTROINTESTINAL SURGERY, 2010, 14 (04) : 679 - 687
  • [8] Risk Factors Influencing Recurrence, Patterns of Recurrence, and the Efficacy of Adjuvant Therapy After Radical Resection for Gallbladder Carcinoma
    Woo Seok Kim
    Dong Wook Choi
    Dong Do You
    Chuan Yu Ho
    Jin Seok Heo
    Seong Ho Choi
    Journal of Gastrointestinal Surgery, 2010, 14 : 679 - 687
  • [9] Challenges in Adjuvant Immunotherapy after Resection or Ablation for Hepatocellular Carcinoma at High-Risk of Recurrence
    Kudo, Masatoshi
    LIVER CANCER, 2024, 13 (06) : 573 - 578
  • [10] Risk factors for different patterns of recurrence after resection of hepatocellular carcinoma
    Kaibori, Masaki
    Matsui, Yoichi
    Saito, Takamichi
    Kamiyama, Yasuo
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2809 - 2816
12345